152 related articles for article (PubMed ID: 7651416)
21. The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16.
Kanto S; Chiba N; Tanaka Y; Fujita S; Endo M; Kamada N; Yoshikawa K; Fukuzaki A; Orikasa S; Watanabe T; Satake M
Leukemia; 2000 Jul; 14(7):1253-9. PubMed ID: 10914550
[TBL] [Abstract][Full Text] [Related]
22. Cbfbeta reduces Cbfbeta-SMMHC-associated acute myeloid leukemia in mice.
Heilman SA; Kuo YH; Goudswaard CS; Valk PJ; Castilla LH
Cancer Res; 2006 Dec; 66(23):11214-8. PubMed ID: 17145866
[TBL] [Abstract][Full Text] [Related]
23. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
[TBL] [Abstract][Full Text] [Related]
24. Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF.
Lu J; Maruyama M; Satake M; Bae SC; Ogawa E; Kagoshima H; Shigesada K; Ito Y
Mol Cell Biol; 1995 Mar; 15(3):1651-61. PubMed ID: 7862156
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of leukemogenesis by the inv(16) chimeric gene CBFB/PEBP2B-MHY11.
Shigesada K; van de Sluis B; Liu PP
Oncogene; 2004 May; 23(24):4297-307. PubMed ID: 15156186
[TBL] [Abstract][Full Text] [Related]
26. c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein.
Bernardin F; Yang Y; Civin CI; Friedman AD
Cancer Biol Ther; 2002; 1(5):492-6. PubMed ID: 12496475
[TBL] [Abstract][Full Text] [Related]
27. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
28. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
29. Transforming properties of the leukemic inv(16) fusion gene CBFB-MYH11.
Hajra A; Liu PP; Collins FS
Curr Top Microbiol Immunol; 1996; 211():289-98. PubMed ID: 8585960
[No Abstract] [Full Text] [Related]
30. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain.
Bae SC; Takahashi E; Zhang YW; Ogawa E; Shigesada K; Namba Y; Satake M; Ito Y
Gene; 1995 Jul; 159(2):245-8. PubMed ID: 7622058
[TBL] [Abstract][Full Text] [Related]
31. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
[TBL] [Abstract][Full Text] [Related]
32. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
Zent C; Rowley JD; Nucifora G
Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
[TBL] [Abstract][Full Text] [Related]
33. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
34. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
[TBL] [Abstract][Full Text] [Related]
35. The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia.
Kogan SC; Lagasse E; Atwater S; Bae SC; Weissman I; Ito Y; Bishop JM
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11863-8. PubMed ID: 9751756
[TBL] [Abstract][Full Text] [Related]
36. AML1 is expressed in skeletal muscle and is regulated by innervation.
Zhu X; Yeadon JE; Burden SJ
Mol Cell Biol; 1994 Dec; 14(12):8051-7. PubMed ID: 7969143
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.
Kurokawa M; Tanaka T; Tanaka K; Ogawa S; Mitani K; Yazaki Y; Hirai H
Oncogene; 1996 Feb; 12(4):883-92. PubMed ID: 8632911
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.
Satake M; Nomura S; Yamaguchi-Iwai Y; Takahama Y; Hashimoto Y; Niki M; Kitamura Y; Ito Y
Mol Cell Biol; 1995 Mar; 15(3):1662-70. PubMed ID: 7862157
[TBL] [Abstract][Full Text] [Related]
39. A new transcription factor family associated with human leukemias.
Speck NA; Terryl S
Crit Rev Eukaryot Gene Expr; 1995; 5(3-4):337-64. PubMed ID: 8834230
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
